# Frédéric Houssiau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/frederic-houssiau/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,236 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 57 |
| i10-index | 124 |
| Last Known Institution | Cliniques Universitaires Saint-Luc |
| OpenAlex ID | https://openalex.org/A5027317477 |
| ORCID iD | 0000-0003-1451-083X |
| Works | 318 |

## Researcher papers

Showing 12 of 16.

- [2019 update of the EULAR recommendations for the management of systemic lupus erythematosus](https://scholariq.org/papers/2019-update-of-the-eular-recommendations-for-the-management-of-systemic-lupus/)
- [Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide](https://scholariq.org/papers/immunosuppressive-therapy-in-lupus-nephritis-the-euro-lupus-nephritis-trial-a/)
- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis](https://scholariq.org/papers/two-year-randomized-controlled-trial-of-belimumab-in-lupus-nephritis/)
- [EULAR recommendations for the management of systemic lupus erythematosus: 2023 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-2023/)
- [Systemic Lupus Erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-2/)
- [Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides](https://scholariq.org/papers/interleukin-6-in-synovial-fluid-and-serum-of-patients-with-rheumatoid-arthritis/)
- [2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis](https://scholariq.org/papers/2019-update-of-the-joint-european-league-against-rheumatism-and-european-renal/)
- [Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6](https://scholariq.org/papers/paracrine-rather-than-autocrine-regulation-of-myeloma-cell-growth-and/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [2021 DORIS definition of remission in SLE: final recommendations from an international task force](https://scholariq.org/papers/2021-doris-definition-of-remission-in-sle-final-recommendations-from-an/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [Cliniques Universitaires Saint-Luc](https://scholariq.org/institutions/cliniques-universitaires-saint-luc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.